Volato Group Inc (NYSEAMERICAN:SOAR) experienced a sharp rally in after-hours trading on Friday after a regulatory filing disclosed that Catheter Precision Inc (NYSEAMERICAN:VTAK) holds a significant stake in the company. The stock jumped 40.74% to $0.23 in late trading, following a regular session that saw shares close at $0.17, up 9.99%.
The move came after Catheter Precision filed a Schedule 13G with the Securities and Exchange Commission, reporting ownership of 2,941,176 shares of Volato's common stock, representing 7.5% of the class. The shares were acquired through a securities purchase agreement dated June 7, with the transaction closing on June 18, according to the filing.
The stake was valued at approximately $1 million based on the $0.34 per share price paid in the private placement. That figure represents roughly 45% of the $2.21 million that Volato raised from the sale of 6.5 million shares in the PIPE (private investment in public equity) deal.
Trading activity on Friday was notably elevated, with 63.28 million shares changing hands during the regular session. That volume was approximately 61% higher than the 39,336,982 shares outstanding listed in Volato's 13G filing, which reflects the post-PIPE share count. The heavy trading volume suggests strong investor interest following the disclosure of the strategic holder.
Despite the after-hours surge, the stock's closing price of $0.17 remains well below the $0.34 PIPE price, representing a discount of roughly 50%. Even after the late-session rally, the stock is still trading about 32% below the PIPE price, indicating that the market is pricing in some caution regarding the potential for selling pressure from registered shares.
Volato's June 18 resale registration filing indicated that the 6.5 million PIPE shares, priced at $0.34 each, can be resold by holders after the registration becomes effective. The company will not receive any proceeds from these resales, as the funds were already collected from the initial PIPE sale. The filing also showed that Catheter Precision holds 2,941,175 shares, while SEG Opportunity Fund LLC and C/M Capital Master Fund LP each own 1,779,412 shares. It is standard practice for such filings to assume all shares in the prospectus will be sold, which does not necessarily indicate an actual sale plan.
Volato has positioned the financing as part of its broader AI-focused aviation strategy. CFO Mark Heinen stated on June 22 that closing the financing at $0.34 per share provides additional capital flexibility and reinforces strategic investor support for the company's next phase. CEO Matt Liotta added on June 15 that the company is evaluating several unsolicited, non-binding letters of intent related to potential AI infrastructure deals, emphasizing the need to separate interesting opportunities from executable ones. Volato also reported that its Vaunt annual recurring revenue reached approximately $4.0 million as of May 2026, a 221% increase year-over-year.
The 13G filing from Catheter Precision clarified that the investment was not made with the intent to control Volato, which should temper any takeover speculation. However, the presence of a large strategic holder and the potential for registered PIPE shares to enter the market could introduce selling pressure in the near term. Investors will be watching closely for any further developments regarding Volato's AI initiatives and the trading activity of its shares.
